425: Horizon Reports Q4 & FY25 Results, Advances Monroe Merger
Quarterly and Annual Financial Results and Merger Update
Horizon Technology Finance Corporation announced its fourth quarter and full year 2025 financial results, highlighting a decrease in net investment income per share and net asset value, while progressing its merger with Monroe Capital Corporation.
Summary
- Net investment income (NII) per basic share for Q4 2025 was $0.18, a decrease from $0.27 in the prior-year period.
- Full Year 2025 NII per basic share was $1.05, down from $1.32 in the prior year.
- Net asset value (NAV) per share stood at $6.98 as of December 31, 2025, compared to $8.43 as of December 31, 2024.
- The total investment portfolio was valued at $647.2 million as of December 31, 2025.
- The annualized portfolio yield on debt investments was 14.3% for Q4 2025 and 15.8% for the full year 2025.
- Horizon ended the year with a committed backlog of $154 million.
- The company funded nine loans totaling $102.5 million in Q4 2025 and 28 loans totaling $277.5 million for the full year 2025.
- Undistributed spillover income was $0.65 per share as of December 31, 2025.
- Monthly distributions of $0.06 per share were declared for April, May, and June 2026.
- Net realized loss on investments was $23.3 million in Q4 2025 and $55.1 million for FY 2025, significantly higher than prior periods.
- Net unrealized appreciation on investments was $24.7 million in Q4 2025 and $10.9 million for FY 2025, an improvement from prior year's depreciation.
- The net debt to equity leverage ratio was 105% as of December 31, 2025, below the company's 120% targeted leverage.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this filing with a cautious sentiment due to significant declines in NII and NAV per share, and increased realized losses. While the merger and portfolio growth initiatives offer future potential, current financial performance shows notable deterioration.
Positives
- Returned to portfolio growth in Q4 2025 through high-quality new venture debt loans.
- Increased committed backlog to $154 million, which is expected to support steady portfolio growth in 2026.
- Experienced net unrealized appreciation on investments of $24.7 million in Q4 2025 and $10.9 million for the full year 2025, a positive shift from prior year's depreciation.
- Maintained a strong annualized portfolio yield on debt investments of 14.3% for Q4 2025 and 15.8% for FY 2025.
- The net debt to equity leverage ratio of 105% is below the company's 120% targeted leverage, indicating prudent financial management.
- Undistributed spillover income of $0.65 per share provides a buffer for future distributions.
Negatives
- Net investment income (NII) per basic share decreased to $0.18 in Q4 2025 from $0.27 in Q4 2024, and to $1.05 for FY 2025 from $1.32 for FY 2024.
- Net asset value (NAV) per share decreased to $6.98 as of December 31, 2025, from $8.43 as of December 31, 2024.
- NII was negatively impacted in Q4 2025 by lower prepayment activity.
- NAV per share was modestly lower due to distributions paid in Q4 exceeding NII.
- Total investment income decreased to $20.7 million in Q4 2025 from $23.5 million in Q4 2024, primarily due to a smaller debt investment portfolio.
- Net realized loss on investments significantly increased to $23.3 million in Q4 2025 from $3.2 million in Q4 2024, and to $55.1 million for FY 2025 from $34.6 million for FY 2024.
- The loan portfolio included four debt investments with an internal credit rating of 1 (highest risk of loss of principal) with an aggregate fair value of $24.5 million as of December 31, 2025.
Risks
- Uncertainties associated with the timing or likelihood of the proposed merger with Monroe Capital Corporation (MRCC) closing.
- The possibility that governmental entities may prohibit, delay, or refuse to grant approval for the merger, or may require conditions, limitations, or restrictions in connection with such approvals.
- The risk that the required approvals by the shareholders of MRCC and/or HRZN may not be obtained.
- The possibility that competing offers or acquisition proposals for the merger will be made.
- Risks related to diverting management's attention from ongoing business operations due to the merger process.
- Changes in the economy, financial markets, and political environment, including the impacts of inflation and interest rates.
- Risks associated with possible disruption in the operations of MRCC and/or HRZN or the economy generally due to terrorism, war or other geopolitical conflict, natural disasters, tariffs or public health crises and epidemics.
- Future changes in laws or regulations (including the interpretation of these laws and regulations by regulatory authorities).
- Conditions in MRCC's and HRZN's operating areas, particularly with respect to business development companies or regulated investment companies.
- There is no assurance that the market price of HRZN's shares, either absolutely or relative to net asset value, will increase as a result of any share repurchases, to the extent effectuated, or that any repurchase plan will enhance shareholder value over the long term.
Future Outlook
Horizon anticipates that the planned merger with Monroe Capital Corporation will provide significant capital for investment, enhance its ability to secure larger venture lending transactions, and ultimately improve Net Investment Income (NII) and Net Asset Value (NAV) over time, creating long-term shareholder value. The company expects steady portfolio growth in 2026, supported by its increased committed backlog.
Management Comments
- "We returned to portfolio growth in the fourth quarter via a number of high-quality new venture debt loans while we made progress toward our planned merger with Monroe Capital Corporation (MRCC)." Mike Balkin, Chief Executive Officer of Horizon.
- "NII was impacted in the quarter by lower prepayment activity, while NAV per share was modestly lower due to our distributions paid in the fourth quarter exceeding our NII." Mike Balkin, Chief Executive Officer of Horizon.
- "Our Board declared a monthly distribution of $0.06 per share for each of April, May and June, which we believe aligns our distribution level with our anticipated NII and operating results for 2026, taking into account the expected impact of the anticipated merger with MRCC." Mike Balkin, Chief Executive Officer of Horizon.
- "In terms of our portfolio, we were pleased to increase our committed backlog during the quarter, which we believe sets a foundation to lead to steady portfolio growth in 2026." Mike Balkin, Chief Executive Officer of Horizon.
- "As we move ahead, we remain excited to complete the merger with MRCC, which will provide us significant capital to invest and, along with our active relationship with Monroe Capital, will better position us to win larger venture lending transactions. This will allow us to enhance our NII and NAV over time, which will ultimately create long-term value for our shareholders." Mike Balkin, Chief Executive Officer of Horizon.
Industry Context
StockSavvy.ai notes that the venture debt market continues to navigate a dynamic environment, with companies like Horizon focusing on strategic mergers to enhance capital access and market positioning. The emphasis on high-quality new loans and increasing committed backlog suggests a proactive approach to growth amidst fluctuating prepayment activity, which is a common variable in this sector. The merger with Monroe Capital Corporation could significantly alter Horizon's competitive landscape by enabling larger transaction participation, a trend seen among specialty finance firms seeking scale.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Credit Facility Amendment | On February 6, 2026, the Company amended its Key Facility to modify certain provisions regarding eligibility of debt investments and concentration limits. | February 6, 2026 | Aims to optimize the use of the credit facility and manage portfolio risk, potentially impacting future lending strategy and liquidity management. |
Related Party Transactions
- Horizon Technology Finance Corporation is externally managed by Horizon Technology Finance Management LLC, an affiliate of Monroe Capital.
- The company is progressing with a planned merger with Monroe Capital Corporation (MRCC), which is also an affiliate of Monroe Capital.
Stakeholder Impact
- Shareholders: Experienced lower NII and NAV per share, but are positioned for potential long-term value creation from the anticipated merger and portfolio growth. Distributions are maintained at $0.06 per share monthly for the next quarter, aligned with anticipated NII post-merger.
- Customers (Portfolio Companies): Will continue to have access to venture debt capital, with an expectation of enhanced capabilities for larger transactions post-merger.
- Creditors: The company maintains a net debt to equity leverage ratio below its target and a healthy asset coverage ratio, indicating sound financial standing relative to its debt obligations.
Next Steps
- Complete the planned merger with Monroe Capital Corporation (MRCC).
- Invest significant capital from the merger to win larger venture lending transactions.
- Host a conference call on March 4, 2026, at 9:00 a.m. ET to discuss financial results and corporate developments.
- Pay monthly distributions of $0.06 per share in April, May, and June 2026.
Key Dates
| Date | Description |
|---|---|
| October 17, 2024 | Company entered into a note purchase agreement for $20.0 million aggregate principal of 7.125% convertible notes due 2031. |
| December 31, 2024 | End of prior fiscal year for comparison. |
| April 17, 2025 | HRZN's definitive proxy statement for its 2025 Annual Meeting of Stockholders filed with the SEC. |
| April 21, 2025 | MRCC's proxy statement for its 2025 Annual Meeting of Stockholders filed with the SEC. |
| May 15, 2025 | Amendment to HRZN's definitive proxy statement for its 2025 Annual Meeting of Stockholders filed with the SEC. |
| September 4, 2025 | Company entered into a note purchase agreement for $40.0 million aggregate principal of 5.50% convertible notes due 2030. |
| September 30, 2025 | End of Q3 2025, used for portfolio asset quality comparison. |
| December 31, 2025 | End of Q4 and Full Year 2025 reporting period. |
| January 7, 2026 | Start of period for 2030 Convertible Notes conversion activity. |
| January 12, 2026 | Funded $30.0 million debt investment to Pelthos Therapeutics, Inc. |
| January 15, 2026 | Distribution of $0.11 per share payable (declared Oct 22, 2025). |
| January 16, 2026 | Company distributed investment held by HIMV LLC to Horizon Technology Finance Corporation. |
| January 20, 2026 | Funded $20.0 million debt investment to Ossio, Inc. |
| January 27, 2026 | Company dissolved HIMV LLC. |
| January 27, 2026 | Company borrowed $20.0 million on the Key Facility. |
| January 28, 2026 | Company redeemed outstanding principal balance of its 4.875% Notes due 2026. |
| February 6, 2026 | Company amended its Key Facility. |
| February 13, 2026 | End of period for 2030 Convertible Notes conversion activity. |
| February 27, 2026 | Board declared monthly distributions of $0.06 per share for April, May, and June 2026. |
| March 3, 2026 | Date of this announcement. |
| March 4, 2026 | Conference call to discuss financial results. |
| March 16, 2026 | Ex-dividend and record date for April 15, 2026 distribution. |
| April 15, 2026 | Payment date for $0.06 per share distribution. |
| April 16, 2026 | Ex-dividend and record date for May 15, 2026 distribution. |
| May 15, 2026 | Payment date for $0.06 per share distribution. |
| May 18, 2026 | Ex-dividend and record date for June 16, 2026 distribution. |
| June 16, 2026 | Payment date for $0.06 per share distribution. |
Recommendation
holdThe significant declines in Net Investment Income and Net Asset Value per share, coupled with increased realized losses, present a negative short-term outlook. However, the strategic merger with Monroe Capital Corporation, the return to portfolio growth in Q4, and the increased committed backlog offer a compelling long-term growth narrative. The current distribution level is aligned with anticipated NII post-merger, suggesting stability. Investors should hold to observe the successful execution and integration of the merger, which is expected to enhance NII and NAV over time, but the immediate financial performance warrants caution.
Keywords
Venture Debt, Specialty Finance, Financial Results, Merger, Monroe Capital, Horizon Technology Finance, Investment Income, Net Asset Value, Portfolio Yield, Credit Quality, Liquidity, Capital Resources, Distributions, Technology Finance, Life Science Finance, Healthcare Information Finance, Sustainability Finance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.